Roser Pons

3.5k total citations
58 papers, 1.6k citations indexed

About

Roser Pons is a scholar working on Clinical Biochemistry, Molecular Biology and Neurology. According to data from OpenAlex, Roser Pons has authored 58 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Clinical Biochemistry, 21 papers in Molecular Biology and 13 papers in Neurology. Recurrent topics in Roser Pons's work include Metabolism and Genetic Disorders (28 papers), Mitochondrial Function and Pathology (10 papers) and Amino Acid Enzymes and Metabolism (8 papers). Roser Pons is often cited by papers focused on Metabolism and Genetic Disorders (28 papers), Mitochondrial Function and Pathology (10 papers) and Amino Acid Enzymes and Metabolism (8 papers). Roser Pons collaborates with scholars based in Greece, United States and Spain. Roser Pons's co-authors include Darryl C. De Vivo, Kristin Engelstad, Toni S. Pearson, Carolyn M. Sue, Michael Rotstein, Rafael Artuch, Claudia A. Chiriboga, Roula Ghaoui, Thomas Opladen and Manju A. Kurian and has published in prestigious journals such as Neurology, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Roser Pons

55 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roser Pons Greece 21 826 644 322 273 261 58 1.6k
Thomas Opladen Germany 24 860 1.0× 782 1.2× 290 0.9× 478 1.8× 191 0.7× 84 1.9k
Mercè Pineda Spain 26 234 0.3× 995 1.5× 199 0.6× 407 1.5× 642 2.5× 54 2.0k
Andrea Whitney United Kingdom 15 691 0.8× 340 0.5× 178 0.6× 231 0.8× 982 3.8× 19 1.6k
Irina Anselm United States 16 477 0.6× 810 1.3× 108 0.3× 303 1.1× 122 0.5× 29 1.2k
Andreea Nissenkorn Israel 25 228 0.3× 729 1.1× 294 0.9× 314 1.2× 83 0.3× 59 1.5k
Warren D. Grover United States 21 442 0.5× 592 0.9× 129 0.4× 139 0.5× 230 0.9× 61 1.3k
D. C. DeVivo United States 21 831 1.0× 961 1.5× 238 0.7× 69 0.3× 365 1.4× 28 1.6k
Katherine B. Howell Australia 23 171 0.2× 753 1.2× 310 1.0× 753 2.8× 156 0.6× 47 2.0k
Per Åmark Sweden 19 261 0.3× 513 0.8× 144 0.4× 127 0.5× 442 1.7× 39 1.5k
James H. Tonsgard United States 20 235 0.3× 455 0.7× 131 0.4× 72 0.3× 140 0.5× 43 1.4k

Countries citing papers authored by Roser Pons

Since Specialization
Citations

This map shows the geographic impact of Roser Pons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roser Pons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roser Pons more than expected).

Fields of papers citing papers by Roser Pons

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roser Pons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roser Pons. The network helps show where Roser Pons may publish in the future.

Co-authorship network of co-authors of Roser Pons

This figure shows the co-authorship network connecting the top 25 collaborators of Roser Pons. A scholar is included among the top collaborators of Roser Pons based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roser Pons. Roser Pons is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pons, Roser, Toni S. Pearson, Belén Pérez‐Dueñas, et al.. (2025). Development and Preliminary Validation of a Parkinsonism‐Dystonia Scale for Infants and Young Children. Movement Disorders. 40(8). 1669–1679. 1 indexed citations
2.
Hübschmann, Oya Kuseyri, Roser Pons, Toni S. Pearson, et al.. (2025). Consensus Guideline for the Diagnosis and Treatment of Tyrosine Hydroxylase ( TH ) Deficiency. Journal of Inherited Metabolic Disease. 48(6). e70106–e70106.
3.
Papadopoulos, Constantinos, Elisabeth Chroni, Roser Pons, et al.. (2024). Myotonia congenita in a Greek cohort: Genotype spectrum and impact of the CLCN1:c.501C > G variant as a genetic modifier. Muscle & Nerve. 70(2). 240–247.
4.
Tzetis, Maria, Talia Kakourou, Christina Kanaka‐Gantenbein, et al.. (2023). Characteristics of Café-au-lait Macules and their Association with the Neurofibromatosis type I Genotype in a Cohort of Greek Children. Acta Dermato Venereologica. 103. adv5758–adv5758. 5 indexed citations
5.
Papadopoulou, Μarianna, et al.. (2023). Translation, reliability and validity of the Greek version of the Child Engagement in Daily Life in children with cerebral palsy. Child Care Health and Development. 50(1). e13202–e13202. 1 indexed citations
6.
Toulas, Panagiotis, Georgios Koutsis, Maria‐Eleftheria Evangelopoulos, et al.. (2022). Natalizumab therapy in patients with pediatric-onset multiple sclerosis in Greece: clinical and immunological insights of time-long administration and future directions—a single-center retrospective observational study. Naunyn-Schmiedeberg s Archives of Pharmacology. 395(8). 933–943. 9 indexed citations
7.
Paramera, Efstathia I., et al.. (2022). Cerebrospinal Fluid Concentrations of Neurotransmitters in a Greek Pediatric Reference Population. Neuropediatrics. 54(2). 126–133. 2 indexed citations
8.
Marais, Anett, Aida M. Bertoli‐Avella, Christian Beetz, et al.. (2022). Further clinical and genetic evidence of ASC-1 complex dysfunction in congenital neuromuscular disease. European Journal of Medical Genetics. 65(8). 104537–104537. 4 indexed citations
9.
Scarmeas, Nikolaos, et al.. (2021). Dystonia assessment in children with cerebral palsy and periventricular leukomalacia. European Journal of Paediatric Neurology. 32. 8–15. 6 indexed citations
10.
Artemiadis, Artemios, Roser Pons, Sotiria Mastroyianni, et al.. (2020). HLA-DRB1 allele impact on pediatric multiple sclerosis in a Hellenic cohort. Multiple Sclerosis Journal - Experimental Translational and Clinical. 6(1). 2455328014–2455328014. 10 indexed citations
11.
Carecchio, Miryam, Niccolò E. Mencacci, Alessandro Iodice, et al.. (2017). ADCY5-related movement disorders: Frequency, disease course and phenotypic variability in a cohort of paediatric patients. Parkinsonism & Related Disorders. 41. 37–43. 56 indexed citations
12.
Wassenberg, Tessa, Marta Molero-Luís, Kathrin Jeltsch, et al.. (2017). Consensus guideline for the diagnosis and treatment of aromatic l-amino acid decarboxylase (AADC) deficiency. Orphanet Journal of Rare Diseases. 12(1). 12–12. 156 indexed citations
13.
Opladen, Thomas, Elisenda Cortès‐Saladelafont, Mario Mastrangelo, et al.. (2016). The International Working Group on Neurotransmitter related Disorders (iNTD): A worldwide research project focused on primary and secondary neurotransmitter disorders. Molecular Genetics and Metabolism Reports. 9. 61–66. 39 indexed citations
14.
Ortez, C., Sofia Duarte, Aída Ormazábal, et al.. (2014). Cerebrospinal fluid synaptic proteins as useful biomarkers in tyrosine hydroxylase deficiency. Molecular Genetics and Metabolism. 114(1). 34–40. 11 indexed citations
15.
Pons, Roser, et al.. (2011). Congenital Cataracts, Facial Dysmorphism, and Neuropathy Syndrome. Pediatric Neurology. 45(3). 206–208. 3 indexed citations
16.
Pons, Roser, Ester Cuenca-León, Elena Miravet, et al.. (2011). Paroxysmal non-kinesigenic dyskinesia due to a PNKD recurrent mutation: Report of two Southern European families. European Journal of Paediatric Neurology. 16(1). 86–89. 15 indexed citations
17.
Pons, Roser, Mercedes Serrano, Aída Ormazábal, et al.. (2010). Tyrosine hydroxylase deficiency in three Greek patients with a common ancestral mutation. Movement Disorders. 25(8). 1086–1090. 17 indexed citations
18.
Pons, Roser, Antoni L. Andreu, Nicoletta Checcarelli, et al.. (2004). Mitochondrial DNA abnormalities and autistic spectrum disorders. The Journal of Pediatrics. 144(1). 81–85. 102 indexed citations
19.
Minetti, Carlo, Barbara Garavaglia, M. Bado, et al.. (1998). Very-long-chain acyl-coenzyme A dehydrogenase deficiency in a child with recurrent myoglobinuria. Neuromuscular Disorders. 8(1). 3–6. 20 indexed citations
20.
Pons, Roser, Francesca Andreetta, Ching H. Wang, et al.. (1996). Mitochondrial myopathy simulating spinal muscular atrophy. Pediatric Neurology. 15(2). 153–158. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas Opladen Breakdown of academic impact, for papers by Mercè Pineda Breakdown of academic impact, for papers by Andrea Whitney Breakdown of academic impact, for papers by Irina Anselm Breakdown of academic impact, for papers by Andreea Nissenkorn Breakdown of academic impact, for papers by Warren D. Grover Breakdown of academic impact, for papers by D. C. DeVivo Breakdown of academic impact, for papers by Katherine B. Howell Breakdown of academic impact, for papers by Per Åmark Breakdown of academic impact, for papers by James H. Tonsgard
Rankless by CCL
2026